Compare Canadian National Railway Co. (CNI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canadian National Railway Co. vs Regeneron Pharmaceuticals Inc — how do they compare? Canadian National Railway Co. trades at $126.3 (market cap $76.28B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Canadian National Railway Co. and Regeneron Pharmaceuticals Inc are close in size by market cap, and Canadian National Railway Co. pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| CNI | REGN | |
|---|---|---|
Market Cap | $76.28B | $82.06B |
Sector | Industrials | Health |
52-Week High | $130.58 | $812.27 |
52-Week Low | $90.91 | $555.51 |
Enterprise Value | $92.31B | $76.77B |
Dividend Yield | 2.06% | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canadian National Railway Co.
Canadian National's railway spans Canada from coast to coast and extends through Chicago to the Gulf of Mexico. In 2019, CN delivered almost 6 million carloads over its 19,600 miles of track. CN generated roughly CAD 14 billion in total revenue by hauling intermodal containers (25% of consolidated revenue), petroleum and chemicals (21%), grain and fertilizers (16%), forest products (12%), metals and mining (11%), automotive shipments (6%), and coal (4%). Other items constitute the remaining revenue.
Read more on CNI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
